Laboratory Stock

$249.62

1.58% day before yesterday

NYSE, Jul 11, 10:00 pm CET

ISIN

US50540R4092

Symbol

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Health

Industry

Health service provider

Overview Dividends Analysts Charts News Strategies

Laboratory Stock price

$249.62

+96.48 63.00% 5Y

NYSE, Closing price Fri, Jul 11 2025

-4.01 1.58%

ISIN

US50540R4092

Symbol

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Health

Industry

Health service provider

Key metrics

Basic

Market capitalization

$20.9b

Enterprise Value

$26.2b

Net debt

$5.3b

Cash

$369.4m

Shares outstanding

83.8m

Valuation (TTM | estimate)

P/E

28.8 | 15.1

P/S

1.6 | 1.5

EV/Sales

2.0 | 1.8

EV/FCF

22.7

P/B

2.5

Dividends

DPS

$2.88

Yield 1Y | 5Y

1.2% | 0.7%

Growth 1Y | 5Y

7.6% | -

Payout 1Y | 3Y

32.6% | 26.9%

Increased

3 Years

Financials (TTM | estimate)

Revenue

$13.2b | $14.3b

EBITDA

$1.4b | $2.5b

EBIT

$1.1b | $2.0b

Net Income

$730.8m | $1.4b

Free Cash Flow

$1.2b

Growth (TTM | estimate)

Revenue

7.1% | 10.0%

EBITDA

5.1% | 76.9%

EBIT

2.6% | 76.3%

Net Income

68.7% | 86.2%

Free Cash Flow

68.6%

Financial Health

Equity Ratio

43.8%

Return on Equity

9.3%

ROCE

7.4%

ROIC

5.5%

Debt/Equity

0.7

EPS

$8.7

FCF per Share

$13.7

Short interest

5.3%

Employees

65k

Rev per Employee

$200.0k

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Get Started for Free Today

Laboratory Stock Analysis

Unlock Scores for Free

??

29 Analysts have issued a Laboratory forecast:

25x Buy

86%

More details on Analyst Estimates Including Price Targets

29 Analysts have issued a Laboratory forecast:

Buy

86%

Hold

14%

Analyst Estimates with Stock Price Targets

Financial data from Laboratory

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	13,177 13,177	7% 7% 100%
- Direct Costs	9,502 9,502	7% 7% 72%
Gross Profit	3,675 3,675	8% 8% 28%
- Selling and Administrative Expenses	2,268 2,268	9% 9% 17%
- Research and Development Expense	- -	- -
EBITDA	1,408 1,408	5% 5% 11%
- Depreciation and Amortization	266 266	17% 17% 2%
EBIT (Operating Income) EBIT	1,142 1,142	3% 3% 9%
Net Profit	731 731	69% 69% 6%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Laboratory Stock News

Neutral

PRNewsWire

●

3 days ago

Labcorp Declares Quarterly Dividend

BURLINGTON, N.C. , July 10, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.

Positive

Seeking Alpha

●

13 days ago

Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low

In my follow-up article on Labcorp, I am upgrading it to a 'Buy' this time. Macro forecasts and the firm's own portfolio growth of solutions and locations could drive more tailwinds to the top line. Leverage risk remains modest in comparison to equity and vs. key peers when considering the D/E and quick ratio.

Neutral

PRNewsWire

●

17 days ago

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

BURLINGTON, N.C. , June 26, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2025 before the market opens on Thursday, July 24, 2025.

More Laboratory News

Company Profile

Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Head office	United States
CEO	Adam Schechter
Employees	65,450
Founded	1971
Website	www.labcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now